GlobeNewswire Inc.··NaAscendis Pharma Shifts to Direct Nasdaq Listing, Eyes Broader Investor Access
Ascendis Pharma to convert ADS shares to direct Nasdaq listing on 1:1 basis effective April 2026, aiming to expand investor access and index eligibility.
ASNDinstitutional ownershipbiopharmaceutical